Journal of Neurology

, Volume 253, Issue 5, pp 612–617 | Cite as

Neurological complications after cadaveric and living donor liver transplantation

  • F. Saner
  • Y. Gu
  • S. Minouchehr
  • K. Ilker
  • N. R. Fruhauf
  • A. Paul
  • A. Radtke
  • M. Dammann
  • Z. Katsarava
  • S. Koeppen
  • M. Malagó
  • Ch. E. Broelsch
ORIGINAL COMMUNICATION

Abstract

Problems related to the central nervous system have a major impact on survival and quality of life. The aim of this retrospective study was to evaluate the incidence of neurological complications after liver transplantation (LT), including both cadaveric and living donor liver transplantation. Between April 2001 and March 2004 174 patients (120 cadaveric liver transplantations, 54 living donor transplantations) were admitted to our intensive care after liver transplantation. Of the transplanted patients 24.7% developed neurological complications. These patients’ stay in the intensive care (14.2 ± 17.2 days) was much longer than that of all admitted patients (8.4 ± 10.5 days, p < 0.05). The most common neurological complications were encephalopathy (72.1%) and seizures (11.6 %). The incidence of neurological complications in living donor liver transplanted patients was significantly lower than in cadaveric transplantation patients (20.4% vs 26.7 %). The cold ischemia time in living donor transplanted patients was significantly shorter in comparison with cadaveric transplanted patients (215 ± 119.3 vs. 383.7 ± 214.7). The survival rate after liver transplantation of patients with neurological complications was lower than that of patients without, but not significantly different (79.1 % vs. 82.4%, p > 0.05). The incidence of neurological symptoms was found to be similar between the patients treated with cyclosporine (25%) and tacrolimus (23.8 %) in this study. In conclusion, there was a high incidence of neurological complications after LT, prolonging the patients’ stay in intensive care significantly. The major neurological manifestation in our patients was encephalopathy followed by seizures. Living donor liver transplantation was associated with a significantly lower incidence of neurological complications compared with patients who had received a cadaveric graft. This might be due to the good quality of the organ and the much shorter cold ischemia time of the graft when the donor was alive.

Key words

encephalopathy liver transplantation neurological complication immunosuppression living donor 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adams DH, Ponsford S, Gunson B, Boon A, Honigsberger L, Williams A, Buckels J, Elias E, McMaster P (1987) Neurological complications following liver transplantation. Lancet 1:949–951PubMedCrossRefGoogle Scholar
  2. 2.
    Bechstein WO (2000) Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 13:313–326PubMedCrossRefGoogle Scholar
  3. 3.
    Broelsch CE, Emond JC, Thistlethwaite JR, Whitington PF, Zucker AR, Baker AL, Aran PF, Rouch DA, Lichtor JL (1988) Liver transplantation, including the concept of reduced-size liver transplants in children. Ann Surg 208:410–420PubMedGoogle Scholar
  4. 4.
    Bronster DJ, Emre S, Mor E, Sheiner P, Miller CM, Schwartz ME (1994) Neurologic complications of orthotopic liver transplantation. Mt Sinai J Med 61:63–69PubMedGoogle Scholar
  5. 5.
    Buckels JA (1995) Liver transplantation: current status, complications and prevention. J Antimicrob Chemother 36(Suppl B):39–49PubMedGoogle Scholar
  6. 6.
    de Groen PC, Aksamit AJ, Rakela J, Forbes GS, Krom RA (1987) Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med 317:861–866PubMedCrossRefGoogle Scholar
  7. 7.
    Estol CJ, Lopez O, Brenner RP, Martinez AJ (1989) Seizures after liver transplantation: a clinicopathologic study. Neurology 39:1297–1301PubMedGoogle Scholar
  8. 8.
    Ferreiro JA, Robert MA, Townsend J, Vinters HV (1992) Neuropathologic findings after liver transplantation. Acta Neuropathol (Berl) 84:1–14PubMedCrossRefGoogle Scholar
  9. 9.
    Freise CE, Rowley H, Lake J, Hebert M, Ascher NL, Roberts JP (1991) Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient. Transplant Proc 23:3173–3174PubMedGoogle Scholar
  10. 10.
    Fruhauf NR, Koeppen Dagger S, Saner FH, Egelhof Dagger T, Stavrou G, Nadalin S, Broelsch CE (2003) Late onset of tacrolimus-related posterior leukoencephalopathy after living donor liver transplantation. Liver Transpl 9:983–985PubMedCrossRefGoogle Scholar
  11. 11.
    Ghaus N, Bohlega S, Rezeig M (2001) Neurological complications in liver transplantation. J Neurol 248:1042–1048PubMedCrossRefGoogle Scholar
  12. 12.
    Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334: 494–500PubMedCrossRefGoogle Scholar
  13. 13.
    Kawasaki S, Makuuchi M, Matsunami H, Hashikura Y, Ikegami T, Nakazawa Y, Chisuwa H, Terada M, Miyagawa S (1998) Living related liver transplantation in adults. Ann Surg 227:269–274PubMedCrossRefGoogle Scholar
  14. 14.
    Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K, Egawa H, Fujita S, Hayashi M, Tanaka K (1999) Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 67:321–327PubMedCrossRefGoogle Scholar
  15. 15.
    Lewis MB, Howdle PD (2003) Neurologic complications of liver transplantation in adults. Neurology 61:1174–1178PubMedGoogle Scholar
  16. 16.
    Lo CM, Fan ST, Liu CL, Wei WI, Lo RJ, Lai CL, Chan JK, Ng IO, Fung A, Wong J (1997) Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg 226: 261–269; discussion 269–270PubMedCrossRefGoogle Scholar
  17. 17.
    Lopez OL, Estol C, Colina I, Quiroga J, Imvertarza OC, van Thiel DH (1992) Neurological complications after liver retransplantation. Hepatology 16:162–166PubMedGoogle Scholar
  18. 18.
    Malago M, Testa G, Frilling A, Nadalin S, Valentin-Gamazo C, Paul A, Lang H, Treichel U, Cicinnati V, Gerken G, Broelsch CE (2003) Right living donor liver transplantation: an option for adult patients: single institution experience with 74 patients. Ann Surg 238:853–862; discussion 862–863PubMedCrossRefGoogle Scholar
  19. 19.
    Marcos A, Fisher RA, Ham JM, Shiffman ML, Sanyal AJ, Luketic VA, Sterling RK, Posner MP (1999) Right lobe living donor liver transplantation. Transplantation 68:798–803PubMedCrossRefGoogle Scholar
  20. 20.
    Martinez AJ (1998) The neuropathology of organ transplantation: comparison and contrast in 500 patients. Pathol Res Pract 194:473–486PubMedGoogle Scholar
  21. 21.
    McDiarmid SV, Busuttil RW, Ascher NL, Burdick J, D’Alessandro AM, Esquivel C, Kalayoglu M, Klein AS, Marsh JW, Miller CM, et al. (1995) FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the US, Multicenter Trial. Transplantation 59:530–536PubMedGoogle Scholar
  22. 22.
    Menegaux F, Keeffe EB, Andrews BT, Egawa H, Monge H, Concepcion W, So SK, Esquivel CO (1994) Neurological complications of liver transplantation in adult versus pediatric patients. Transplantation 58:447–450PubMedCrossRefGoogle Scholar
  23. 23.
    Miller CM, Gondolesi GE, Florman S, Matsumoto C, Munoz L, Yoshizumi T, Artis T, Fishbein TM, Sheiner PA, Kim-Schluger L, Schiano T, Shneider BL, Emre S, Schwartz ME (2001) One hundred nine living donor liver transplants in adults and children: a singlecenter experience. Ann Surg 234:301–311; discussion 311–312PubMedCrossRefGoogle Scholar
  24. 24.
    Moreno E, Gomez SR, Gonzalez I, Loinaz C, Garcia I, Perez A, Palomo C, Alvarado A, Maffettone V, Perez-Cerda F, et al. (1993) Neurologic complications in liver transplantation. Acta Neurol Scand 87:25–31PubMedCrossRefGoogle Scholar
  25. 25.
    Mueller AR, Platz KP, Bechstein WO, Schattenfroh N, Stoltenburg-Didinger G, Blumhardt G, Christe W, Neuhaus P (1994) Neurotoxicity after orthotopic liver transplantation.A comparison between cyclosporine and FK506. Transplantation 58:155–170PubMedGoogle Scholar
  26. 26.
    Nakamura M, Fuchinoue S, Sato S, Hoshino T, Sawada T, Sageshima J, Kitajima K, Tojinbara T, Fujita S, Nakajima I, Agishi T, Tanaka K (1998) Clinical and radiological features of two cases of tacrolimus-related posterior leukoencephalopathy in living related liver transplantation. Transplant Proc 30:1477–1478PubMedCrossRefGoogle Scholar
  27. 27.
    Nakamura T, Tanaka K, Kiuchi T, Kasahara M, Oike F, Ueda M, Kaihara S, Egawa H, Ozden I, Kobayashi N, Uemoto S (2002) Anatomical variations and surgical strategies in right lobe living donor liver transplantation: lessons from 120 cases. Transplantation 73:1896–1903PubMedCrossRefGoogle Scholar
  28. 28.
    Padovan CS, Sostak P, Straube A (2000) Neurological complications after organ transplantation. Nervenarzt 71:249–258PubMedCrossRefGoogle Scholar
  29. 29.
    Pujol A, Graus F, Rimola A, Beltran J, Garcia-Valdecasas JC, Navasa M, Grande L, Galofre J, Visa J, Rodes J, et al. (1994) Predictive factors of inhospital CNS complications following liver transplantation. Neurology 44:1226–1230PubMedGoogle Scholar
  30. 30.
    Santori G, Andorno E, Morelli N, Antonucci A, Bottino G, Mondello R, Castiglione AG, Valente R, Ravazzoni F, Di Domenico S, Valente U (2005) MELD score versus conventional UNOS status in predicting short-term mortality after liver transplantation. Transpl Int 18:65–72PubMedCrossRefGoogle Scholar
  31. 31.
    Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR (1963) Homotransplantation of the Liver in Humans. Surg Gynecol Obstet 117:659–676PubMedGoogle Scholar
  32. 32.
    Starzl TE, Iwatsuki S, Esquivel CO, Todo S, Kam I, Lynch S, Gordon RD, Shaw BW Jr (1985) Refinements in the surgical technique of liver transplantation. Semin Liver Dis 5:349–356PubMedCrossRefGoogle Scholar
  33. 33.
    Stein DP, Lederman RJ, Vogt DP, Carey WD, Broughan TA (1992) Neurological complications following liver transplantation. Ann Neurol 31:644–649PubMedCrossRefGoogle Scholar
  34. 34.
    Vogt DP, Lederman RJ, Carey WD, Broughan TA (1988) Neurologic complications of liver transplantation. Transplantation 45:1057–1061PubMedGoogle Scholar
  35. 35.
    Wijdicks EF, Wiesner RH, Dahlke LJ, Krom RA (1994) FK506-induced neurotoxicity in liver transplantation. Ann Neurol 35:498–501PubMedCrossRefGoogle Scholar
  36. 36.
    Wijdicks EF, Plevak DJ, Wiesner RH, Steers JL (1996) Causes and outcome of seizures in liver transplant recipients. Neurology 47:1523–1525PubMedGoogle Scholar

Copyright information

© Steinkopff-Verlag 2006

Authors and Affiliations

  • F. Saner
    • 1
  • Y. Gu
    • 1
  • S. Minouchehr
    • 1
  • K. Ilker
    • 2
  • N. R. Fruhauf
    • 1
  • A. Paul
    • 1
  • A. Radtke
    • 1
  • M. Dammann
    • 1
  • Z. Katsarava
    • 2
  • S. Koeppen
    • 2
  • M. Malagó
    • 1
  • Ch. E. Broelsch
    • 1
  1. 1.FACS University Hospital EssenDepartment of General Surgery and TransplantationEssenGermany
  2. 2.Department of NeurologyUniversity Hospital EssenEssenGermany

Personalised recommendations